Your browser doesn't support javascript.
loading
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson, Evelyn M; Dyall, Julie; DeWald, Lisa Evans; King, Steven R; Dube, Derek; Legendre, Maureen; Nelson, Elizabeth; Drews, Kelly C; Gross, Robin; Gerhardt, Dawn M; Torzewski, Lisa; Postnikova, Elena; Liang, Janie Y; Ban, Bhupal; Shetty, Jagathpala; Hensley, Lisa E; Jahrling, Peter B; Olinger, Gene G; White, Judith M; Markovitz, David M.
Afiliação
  • Covés-Datson EM; Medical Scientist Training Program, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Dyall J; Department of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
  • DeWald LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • King SR; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Dube D; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Legendre M; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Nelson E; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Drews KC; Department of Cell Biology, University of Virginia, Charlottesville, Virginia, United States of America.
  • Gross R; Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
  • Gerhardt DM; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Torzewski L; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Postnikova E; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Liang JY; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Ban B; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Shetty J; Department of Cell Biology, University of Virginia, Charlottesville, Virginia, United States of America.
  • Hensley LE; Antibody Engineering and Technology Core, University of Virginia, Charlottesville, Virginia, United States of America.
  • Jahrling PB; Antibody Engineering and Technology Core, University of Virginia, Charlottesville, Virginia, United States of America.
  • Olinger GG; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • White JM; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
  • Markovitz DM; Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.
PLoS Negl Trop Dis ; 13(7): e0007595, 2019 07.
Article em En | MEDLINE | ID: mdl-31356611
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Antivirais / Musa / Lectinas de Plantas / Ebolavirus Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Negl Trop Dis Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Antivirais / Musa / Lectinas de Plantas / Ebolavirus Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Negl Trop Dis Ano de publicação: 2019 Tipo de documento: Article